Related Experiment Videos
A new mutation in the elastin gene causing supravalvular aortic stenosis.
T Boeckel1, A Dierks, A Vergopoulos
1German Heart Center, Section of Pediatric Cardiology, Medical Faculty of the Charité, Humboldt University of Berlin.
The American Journal of Cardiology
|April 6, 1999
Summary
A genetic study identified a mutation in the elastin gene causing supravalvular aortic stenosis. This inherited heart condition showed increasing severity across generations in a large family.
Area of Science:
- Cardiovascular Genetics
- Molecular Biology
- Medical Genetics
Background:
- Supravalvular aortic stenosis (SVAS) is a rare congenital heart defect.
- Genetic mutations, particularly in the elastin gene (ELN), are known causes of SVAS.
- Understanding genotype-phenotype correlations is crucial for predicting disease progression.
Purpose of the Study:
- To describe a kindred with supravalvular aortic stenosis.
- To identify the specific genetic mutation responsible for the disease in this family.
- To investigate the pattern of disease severity across generations.
Main Methods:
- Family history collection and clinical evaluation of affected individuals.
- Genetic analysis, including DNA sequencing of the elastin gene.
- Correlation of identified mutations with clinical phenotypes.
Main Results:
- A large kindred with supravalvular aortic stenosis was identified.
- A specific point mutation in exon 18 and a premature stop codon in exon 22 of the elastin gene were found in affected individuals.
- Clinical observations indicated a progressive increase in disease severity in successive generations.
Conclusions:
- A novel elastin gene mutation is associated with supravalvular aortic stenosis in this family.
- The findings highlight the role of elastin gene defects in the pathogenesis of SVAS.
- Progressive clinical severity suggests potential for genetic anticipation or varying penetrance in this kindred.